Critical Health, an approved Manufacturer of Medical Devices, aims to build a valuable global business of Health Information Technology Products.
The products are focused on preventing Loss of Vision for Diabetics and people older than 65 years in developed countries.
Critical Health is available to discuss other opportunities where to put our competences at the service of our partners.
Retmarker is currently available in two versions:
RetmarkerC a solution that automatically detects the progression of Retinal Changes over time. RetmarkerC uses image processing technology (namelly an advanced, proprietary, co-registration algorithm which automatically overlaps retinographies) and the latest medical research to deliver a product that automatically detects such changes accurately, effectively and effortlessly.
RetmarkerDR is a biomarker for Diabetic Retinopathy progression. It uses the same advanced proprietary co-registration algorithm and complements it with a state-of-the-art Microaneurysm (MA) detector to calculate important ratios regarding MA Turnover (Formation and Disappearance Rates). Latest research on Microaneurysm Turnover point it as the newest and most reliable biomarker for Diabetic Retinopathy progression in a mild non-proliferative stage to Clinically Significant Macular Edema (CSME), a sight-threatening stage. RetmarkerDR includes all features from RetmarkerC.
RetmarkerAMD Research is a new solution that allows computer-assisted grading of digital images from patients with Age-related Macular Degeneration (AMD). This solution, developed for an AMD Epidemiological Study won in London, in 2010, the European IT Excellence Award.
Complementing the Clinical Decision Support solutions, Critical Health has decided to incorporate in its portfolio an Electronic Medical Record (EMR) specialized in Ophthalmology.
Medisoft, the UK's best selling Ophthalmology EMR system, was the chosen partner. Critical Health is proud to announce this partnership to adapt, deploy and support Medisoft Ophthalmology in Portugal, Spain and Latin America. [Learn more]